ArticleBiomedical chromatography : BMC2026
Development and Validation of a HPLC-MS/MS Method for Quantification of Andrographolide in Rat Plasma by Using Lithium Adduct Detection.
Article in Biomedical chromatography : BMC, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
In this study, a simple high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) method has been developed for quantification of andrographolide in rat plasma using andrographolide-lithium adduct as the precursor ion for the first time. The addition of lithium carbonate into the mobile phase could increase the mass response of andrographolide by approximately 100-fold. The analytes were retained and separated on a C18 column and analyzed using a triple quadrupole mass spectrometer equipped with an ESI source. Andrographolide exhibited excellent retention on the C18 column under optimized chromatographic conditions. A simple protein precipitation pretreatment resulted in high extraction recovery (approximately 100%) and negligible matrix effects. The method was linear over the concentration range of 2.00-1606.00 ng/mL. Both precision and accuracy were within acceptable limits. This simple HPLC-MS/MS method has been validated and successfully applied to support pharmacokinetic studies of andrographolide in Sprague-Dawley rats. The present study also provided a strategy for improving the mass response of drugs with low ionization efficiency, especially compounds from plants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.